Globus Medical Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Globus Medical (GMED) PT Raised to $78 at RBC Capital
August 7, 2024 7:00 AM EDTRBC Capital analyst Shagun Singh raised the price target on Globus Medical (NYSE: GMED) to $78.00 (from $76.00) while maintaining a Outperform rating.
The analyst comments "GMED issued Q2 results, delivering an upside surprise of 2% and 11% in sales and EPS, respectively. This was the third consolidated... More
Globus Medical (GMED) PT Raised to $79 at Truist Securities
August 7, 2024 6:08 AM EDTTruist Securities analyst Richard Newitter raised the price target on Globus Medical (NYSE: GMED) to $79.00 (from $78.00) while maintaining a Hold rating.
The analyst comments "GMED delivered a good qtr, post-deal integration with dissynergies no worse than feared, and mgmt appears on... More
Globus Medical (GMED) PT Raised to $100 at Roth/MKM
August 7, 2024 5:17 AM EDTRoth/MKM analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 (from $75.00) while maintaining a Buy rating.
The analyst comments "GMED reported 2Q24 revenues of $629.7 million compared to consensus of $615.3 million, and adjusted EPS of $0.75 compared to consensus of $0.68. Adjusted... More
